抗体-配体基序的设计优化以增强 CAR-T 抗实体瘤重定向活性
Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors.
88.8分
★★★★★
站内排序·非疗效
肿瘤细胞治疗研究
MODALITY HUB
FOR TREATMENT
现在就能报名的(招募中)排在最前,共 0 项。同一状态内中国中心优先。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Design optimization of antibody-ligand motifs to enhance CAR-T redirection activity against solid tumors.
Therapeutic advances in the targeting of ROR1 in hematological cancers.
MEMBER ACCOUNT
登录成功会直接打开下一页。